title: Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.
abstract: Previous studies have shown that in non-Hodgkin's lymphomas and others neoplasms, tumoral progression, treatment response, and outcome are related to the expression of different oncogenic and tumor suppressor proteins. This study aimed to determine the prognostic significance of the expression of p53, bcl2, retinoblastoma protein (Rb), Ki67, CD15, and latent membrane protein 1-Epstein-Barr Virus (LMP1-EBV) proteins in Hodgkin's disease. A retrospective study was performed on 140 patients collected at the 11 participating centers belonging to the Spanish Collaborative Group for the Study of Hodgkin's Disease. A highly sensitive immunohistochemical method with previous microwave-induced antigen retrieval technique was used for the demonstration of the above-mentioned proteins. A Cox's multivariate analysis was performed to evaluate the impact of the variables in the overall survival, together with a logistic regression model for the achievement of complete remission. Univariate statistical analysis confirmed the prognostic significance of the alredy known clinical parameters: stage, age over 60 years, and B symptoms. High proliferation index (Ki67) and loss of Rb expression were also found to be adverse prognostic factors influencing respectively lower overall survival and failure to achieve complete remission. Multivariate analysis confirmed the independent significance of these two parameters and additionally identifies LMP1-EBV expression as a favorable prognostic marker, in relation with overall survival. Histopathological type, p53, bcl2, and CD15 expression lack significant influence on the outcome of this series. The progression of the disease or the response to treatment in HD patients is the consequence of the interrelationship of different factors, among which LMP1 expression, loss of Rb, and high growth fraction seems to play a more relevant role.
authors.affiliation: Department of Pathology, Hospital General Universitario, Universidad de Alcalá, Guadalajara, Spain.
authors.forename: M M
authors.initials: MM
authors.lastname: Morente
authors.forename: M A
authors.initials: MA
authors.lastname: Piris
authors.forename: V
authors.initials: V
authors.lastname: Abraira
authors.forename: A
authors.initials: A
authors.lastname: Acevedo
authors.forename: B
authors.initials: B
authors.lastname: Aguilera
authors.forename: C
authors.initials: C
authors.lastname: Bellas
authors.forename: M
authors.initials: M
authors.lastname: Fraga
authors.forename: R
authors.initials: R
authors.lastname: Garcia-Del-Moral
authors.forename: F
authors.initials: F
authors.lastname: Gomez-Marcos
authors.forename: J
authors.initials: J
authors.lastname: Menarguez
authors.forename: H
authors.initials: H
authors.lastname: Oliva
authors.forename: M
authors.initials: M
authors.lastname: Sanchez-Beato
authors.forename: C
authors.initials: C
authors.lastname: Montalban
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002455:Cell Division; D002648:Child; D002675:Child, Preschool; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism*; D016256:Lewis X Antigen / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D012044:Regression Analysis; D016160:Retinoblastoma Protein / Q000378:metabolism*; D012189:Retrospective Studies; D016019:Survival Analysis; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D014763:Viral Matrix Proteins / Q000378:metabolism*
chemical_list: C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019394:Ki-67 Antigen; D016256:Lewis X Antigen; D019253:Proto-Oncogene Proteins c-bcl-2; D016160:Retinoblastoma Protein; D016159:Tumor Suppressor Protein p53; D014763:Viral Matrix Proteins